Stay updated on Maintenance Therapy Trial: Odetiglucan & CD40 Agonist

Sign up to get notified when there's something new on the Maintenance Therapy Trial: Odetiglucan & CD40 Agonist page.
Latest website image capture
Clouds background image

Latest updates to the Maintenance Therapy Trial: Odetiglucan & CD40 Agonist page

  1. Check
    yesterday
    Change Detected
    Summary
    The NIH funding operating status notice was removed from the page, with no impact on the core study details or user actions. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-18T06:48:51.000Z thumbnail image
  2. Check
    8 days ago
    No Change Detected
  3. Check
    15 days ago
    Change Detected
    Summary
    No significant changes detected between the two screenshots; the page content, including the title and key study details, appears unchanged.
    Difference
    0.5%
    Check dated 2025-11-03T20:43:23.000Z thumbnail image
  4. Check
    44 days ago
    Change Detected
    Summary
    New operating-status notice and version update to v3.2.0 are now present, replacing the previous v3.1.0; this adds important information about potential funding-related service limitations and where to check for status.
    Difference
    3%
    Check dated 2025-10-06T05:07:26.000Z thumbnail image
  5. Check
    51 days ago
    Change Detected
    Summary
    Version updated from v3.0.2 to v3.1.0; no other substantive content changes detected.
    Difference
    0.1%
    Check dated 2025-09-29T02:59:03.000Z thumbnail image
  6. Check
    65 days ago
    Change Detected
    Summary
    Version bump to v3.0.2 from v3.0.1; no core content or data changes detected. The removal of 'Back to Top' is a minor UI adjustment.
    Difference
    0.2%
    Check dated 2025-09-14T18:53:56.000Z thumbnail image
  7. Check
    72 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content.
    Difference
    0.2%
    Check dated 2025-09-07T14:11:06.000Z thumbnail image

Stay in the know with updates to Maintenance Therapy Trial: Odetiglucan & CD40 Agonist

Enter your email address, and we'll notify you when there's something new on the Maintenance Therapy Trial: Odetiglucan & CD40 Agonist page.